SRTS241220P4000
- 0.00
- 0.000.00%
Sensus Healthcare Newsroom
Sensus Healthcare, Inc.'s (NASDAQ:SRTS) Intrinsic Value Is Potentially 92% Above Its Share Price
Wall Street Bulls Look Optimistic About Sensus Healthcare (SRTS): Should You Buy?
Sensus Healthcare Has Partnered With Pompano Veterinary Oncology To Pioneer The Use Of SRT To Treat Companion Animals Across South Florida Via The Use Of A Mobile Van
Here's What Could Help Sensus Healthcare (SRTS) Maintain Its Recent Price Strength
Sensus Healthcare (NASDAQ:SRTS) Knows How To Allocate Capital Effectively
H.C. Wainwright Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Raises Target Price to $11
Sensus Healthcare Is Maintained at Buy by HC Wainwright & Co.
Express News | Sensus Healthcare, Inc. : H.c. Wainwright Raises Target Price to $11 From $10
Express News | Revised - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More Than Doubling Versus 2023 Third Quarter
Press Release: REVISED - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More Than Doubling Versus 2023 Third Quarter
Sensus Healthcare Analyst Ratings
Maxim Group Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Raises Target Price to $14
Roth MKM Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Maintains Target Price $10
Roth MKM Keeps Their Buy Rating on Sensus Healthcare (SRTS)
Sensus Healthcare, Inc. (SRTS) Q3 2024 Earnings Call Transcript Summary
Sensus Healthcare GAAP EPS of $0.07 Beats by $0.08, Revenue of $8.84M Beats by $2.94M
Sensus Healthcare, Inc. (SRTS) Surpasses Q3 Earnings and Revenue Estimates
Sensus Healthcare | 10-Q: Q3 2024 Earnings Report
Express News | Sensus Healthcare Q3 Basic EPS USD 0.07
Express News | Sensus Healthcare Q3 Adjusted Ebitda USD 1.593 Million